These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 7848896)

  • 1. Short and long-acting oral nitrates for stable angina pectoris.
    Thadani U; Lipicky RJ
    Cardiovasc Drugs Ther; 1994 Aug; 8(4):611-23. PubMed ID: 7848896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal nitrate therapy with a once-daily sustained-release formulation of isosorbide mononitrate.
    Waller DG
    J Cardiovasc Pharmacol; 1999 Aug; 34 Suppl 2():S21-7; discussion S29-31. PubMed ID: 10499557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrate tolerance, rebound, and their clinical relevance in stable angina pectoris, unstable angina, and heart failure.
    Thadani U
    Cardiovasc Drugs Ther; 1997 Jan; 10(6):735-42. PubMed ID: 9110117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When does nitrate tolerance develop? What dosages and which intervals are necessary to ensure maintained effectiveness?
    Rudolph W; Dirschinger J; Reiniger G; Beyerle A; Hall D
    Eur Heart J; 1988 Jan; 9 Suppl A():63-72. PubMed ID: 3137072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24 hours a day in 2,456 patients with stable angina pectoris. The Italian Multicenter Study.
    Savonitto S; Motolese M; Agabiti-Rosei E
    Int J Clin Pharmacol Ther; 1995 Apr; 33(4):194-203. PubMed ID: 7620688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-ischaemic response to sublingual nitroglycerin during oral administration of isosorbide dinitrate in patients with stable angina pectoris: when does cross-tolerance occur?
    Kośmicki MA; Szwed H; Sadowski Z
    Cardiovasc Drugs Ther; 2004 Jan; 18(1):47-55. PubMed ID: 15115903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrates: why and how should they be used today? Current status of the clinical usefulness of nitroglycerin, isosorbide dinitrate and isosorbide-5-mononitrate.
    Silber S
    Eur J Clin Pharmacol; 1990; 38 Suppl 1():S35-51. PubMed ID: 2113003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of isosorbide mononitrate in angina pectoris.
    Thadani U; de Vane PJ
    Am J Cardiol; 1992 Nov; 70(17):67G-71G. PubMed ID: 1449103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitrates for angina pectoris. A critical review of therapeutic efficacy and tolerance.
    Thadani U
    Herz; 1984 Jun; 9(3):123-36. PubMed ID: 6430766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma volume expansion may explain the attenuation of antianginal activity of oral isosorbide dinitrate in long-term therapy].
    Kośmicki M; Sadowski Z
    Pol Arch Med Wewn; 1999 Nov; 102(5):967-72. PubMed ID: 11072531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrate cross-tolerance: effect of sublingual isosorbide dinitrate and nitroglycerin during sustained nitrate therapy.
    Dalal JJ; Parker JO
    Am J Cardiol; 1984 Aug; 54(3):286-8. PubMed ID: 6431795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [4 different nitrate preparations with regard to the possible development of tolerance in long-term treatment].
    Mertens HM; Ohlmeier H; Mannebach H; Kabelitz K; Gleichmann U
    Herz; 1985 Jun; 10(3):172-81. PubMed ID: 3926614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrate tolerance.
    Parker JO
    Am J Cardiol; 1985 Dec; 56(17):28I-31I. PubMed ID: 3934952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrate tolerance. A problem during continuous nitrate administration.
    Parker JO
    Eur J Clin Pharmacol; 1990; 38 Suppl 1():S21-5. PubMed ID: 2113001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of extended-release isosorbide mononitrate for stable effort angina pectoris.
    Chrysant SG; Glasser SP; Bittar N; Shahidi FE; Danisa K; Ibrahim R; Watts LE; Garutti RJ; Ferraresi R; Casareto R
    Am J Cardiol; 1993 Dec; 72(17):1249-56. PubMed ID: 8256699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained effect of and lack of development of tolerance to controlled-release isosorbide-5-mononitrate in chronic stable angina pectoris.
    Wisenberg G; Roks C; Nichol P; Goddard MD
    Am J Cardiol; 1989 Sep; 64(10):569-76. PubMed ID: 2782247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrate therapy for stable angina pectoris.
    Parker JD; Parker JO
    N Engl J Med; 1998 Feb; 338(8):520-31. PubMed ID: 9468470
    [No Abstract]   [Full Text] [Related]  

  • 18. Glyceryl trinitrate (nitroglycerin) and the organic nitrates. Choosing the method of administration.
    Abrams J
    Drugs; 1987 Sep; 34(3):391-403. PubMed ID: 3119308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isosorbide mononitrate 30% immediate-release 70% sustained-release formulation: a review. DUMQOL (DUtch Mononitrate Quality of Life) Study Group.
    Cleophas TJ; Niemeyer MG; Zwinderman AH; van der Wall EE
    Angiology; 2000 Aug; 51(8):631-8. PubMed ID: 10959515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained hemodynamic and antianginal effects of high dose oral isosorbide dinitrate.
    Aronow S
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2483-6. PubMed ID: 7422537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.